InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
J-Belfort Free
08/24/20 7:47 AM
profile icon
J-Belfort Free
08/24/20 12:55 AM
profile icon
Money $hot Free
08/23/20 4:46 PM
profile icon
TarheelBuyer Free
08/23/20 6:14 AM
profile icon
DamnedYankeeFan Free
08/23/20 5:41 AM
profile icon
nelskof Free
08/23/20 1:12 AM
profile icon
J-Belfort Free
08/23/20 12:20 AM
profile icon
J-Belfort Free
08/22/20 11:53 PM
profile icon
J-Belfort Free
08/22/20 10:58 PM
profile icon
J-Belfort Free
08/22/20 4:55 PM
profile icon
Curt D PremiumMember
08/22/20 4:04 PM
profile icon
Money $hot Free
08/22/20 3:23 PM
profile icon
TarheelBuyer Free
08/22/20 3:16 PM
profile icon
TarheelBuyer Free
08/22/20 3:14 PM
profile icon
Money $hot Free
08/22/20 3:10 PM
profile icon
Curt D PremiumMember
08/22/20 3:06 PM
profile icon
TarheelBuyer Free
08/22/20 2:56 PM
profile icon
4running Free
08/22/20 2:52 PM
profile icon
Money $hot Free
08/22/20 2:44 PM
profile icon
massulo52 Free
08/22/20 2:31 PM
profile icon
4running Free
08/22/20 2:30 PM
profile icon
Money $hot Free
08/22/20 2:19 PM
profile icon
TarheelBuyer Free
08/22/20 2:11 PM
profile icon
massulo52 Free
08/22/20 2:09 PM
profile icon
Money $hot Free
08/22/20 2:01 PM
profile icon
J-Belfort Free
08/22/20 1:29 PM

Relief Therapeutics Holding AG (RLFTF) RSS Feed

Followers
5
Posters
9
Posts (Today)
0
Posts (Total)
30
Created
08/22/20
Type
Free
Moderators

RELIEF THERAPEUTICS Holding SA
https://www.six-group.com/en/products-services/the-swiss-stock-exchange/market-data/shares/share-explorer/share-details.html?valorId=CH0100191136CHF4#/

 
SIX:RTF



US OTC:Pink RLFTF










 
Website: 

Last Meeting:

CoB:
Vice CoB
CFO:

Board Members:


Auditor: 
Financial Statements
:
Ongoing Trials:

US Trail Partner: 

 
https://relieftherapeutics.com/news/

2020-07-20

Dr. Raghuram Selvaraju
Dr. Jonathan Javitt
TBD

Mr. Peter De Svastich 
Mr. Thomaz Burckhardt.

Mazars
https://relieftherapeutics.com/key-information/

https://clinicaltrials.gov/ct2/results?cond=&term=aviptadil

https://www.neurorxpharma.com/latest-news/













 
Public Term Search Links
Google News: RLF-100,RLFTF
Google Trends: RLF-100,RLFTF
Twitter:  RLF-100
Twitter: RLFTF
Reddit: RLF-100
Reddit: RLFTF

"Relief Therapeutics holds FDA orphan drug designations for the use of VIP to treat ARDS, pulmonary hypertension, and sarcoidosis."
https://www.clinicaltrialsarena.com/news/relief-aviptadil-covid-19-trial-us/

"On 28 August 2006, orphan designation (EU/3/06/395) was granted by the European Commission to mondoBIOTECH Laboratories, Lichtenstein, for Aviptadil for the treatment of acute lung injury."
https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu306395

RLF AG realized what they had might be beneficial to COVID ARDS treatment
https://www.reuters.com/article/brief-relief-therapeutics-to-test-rlf-10/brief-relief-therapeutics-to-test-rlf-100-for-treatment-of-covid-induced-ards-idUSFWN2B91WW

RLF AG teams up with a "Tom Brady" in the pharma industry to get their drug through FDA process
https://www.clinicaltrialsarena.com/news/relief-aviptadil-covid-19-trial-us/

US IV Trial 
https://clinicaltrials.gov/ct2/history/NCT04311697?A=1&B=5&C=merged

Paper on 21 CONSECUTIVE emergency use IND patients (too sick for IV trial)
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3665228





 







































Recent News:
2020-08-26   "Our Expanded Access Program is being managed by Clinigen." 
- Prestige World Wide!  Wide ...Wide..Wide...
2020-08-25    OTCQB Certification
Exchange Uplisting 
2020-08-25   Relief theraputics lists GEM's NYC office as their NYC office
- Interesting
2020-08-20   RLF-100 (Aviptadil) Intermediate Population Expanded Access Protocol (SAMICARE)
- SAMICARE
2020-08-20   Rapid Recovery from COVID-19 Respiratory Failure with Comorbidity in 21 Patients Treated with Vasoactive Intestinal Peptide
- BARDA in Title field of PDF document properties
- First 21 consecutive emergency access patients responded well
- Research support was provided by the Cavendish Impact Foundation and Princeton Alumni Angels.
- Clinical trial funding was provided by Relief Therapeutics Holdings, AG, Geneva and NeuroRx, Inc.
2020-08-12   Dr Yo: Discussion with Dr. Jonathan Javitt about Aviptadil and Vasoactive Intestinal Peptide
- YOOOOO!!!!
2020-08-06   FDA grants inhaled use IND for RLF-100 (aviptadil) to treat patients with moderate and severe COVID-19 aiming to prevent progression to respiratory failure
- Aerosolized Study Approved
2020-08-06   Some Nurse on youtube commenting about COVID  
- She comments and gives her take aways
2020-08-03   RLF-100 (aviptadil) clinical trial showed rapid recovery from respiratory failure and inhibition of coronavirus replication in human lung cells
- Report on first 6 expanded use patients that were too sick to particpate in trial
- 5 of 6 emergency access patients showed rapid improvement and discharged though all intubated and recieving ECMO initially
2020-07-25   Vasoactive Intestinal Peptide treats Respiratory Failure in COVID-19 by rescuing the Alveolar Type II cell
- "Clinical reports are now emerging which document rapid recovery from Critical COVID-19 with respiratory failure within days of administering intravenous RLF-100"
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
RLFTF Latest News
  • No Recent News Available for this company!
New Post